日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Noninvasive Early Detection and Recurrence Monitoring for Non-Muscle-Invasive Bladder Cancer via Urine Tumor DNA: A Prospective Clinical Study

通过尿液肿瘤DNA进行非肌层浸润性膀胱癌的无创早期检测和复发监测:一项前瞻性临床研究

Wu, Junlong; Jin, Shengming; Bai, Qianming; Wang, Huina; Cheng, Huanqing; Zhou, Xiaoyan; Shen, Yijun; Ma, Chunguang; Gu, Chengyuan; Chen, Hui; Zhang, Yafeng; Chen, Libin; Shariat, Shahrokh F; Lou, Feng; Cao, Shanbo; Zhu, Yiping; Ye, Dingwei

Mutational landscape and DNA methylation-based classification of squamous cell carcinoma and urothelial carcinoma

鳞状细胞癌和尿路上皮癌的突变图谱和基于DNA甲基化的分类

Ren, Min; Xu, Midie; Chen, Chen; Wei, Ran; Yao, Qianlan; Jia, Liqing; Qi, Peng; Wang, Qifeng; Bai, Qianming; Zhu, Xiaoli; Wu, Sheng; Xu, Qinghua; Zhou, Xiaoyan

An accurate DNA and RNA based targeted sequencing assay for clinical detection of gene fusions in solid tumors

一种基于DNA和RNA的精准靶向测序方法,用于临床检测实体瘤中的基因融合

Ji, Gang; Yao, Qianlan; Ren, Min; Bai, Qianming; Zhu, Xiaoli; Zhou, Xiaoyan

Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL

TP53基因改变与p53免疫组化表达的相关性及其在弥漫性大B细胞淋巴瘤中的预后意义

Chen, Chen; Hu, Zijuan; Ren, Min; Bao, Longlong; Wei, Ran; Tian, Tian; Zhu, Xiaoli; Bai, Qianming; Yu, Baohua; Li, Xiaoqiu; Zhou, Xiaoyan

Case Report: Gefitinib in EGFR 19del recurrent aggressive fibromatosis

病例报告:吉非替尼治疗EGFR 19del复发性侵袭性纤维瘤病

Guo, Yanjing; Wu, Jingjing; Bai, Qianming; Wan, Juefeng; Wang, Qifeng; He, Xinhong; Zhang, Xiaowei; Luo, Zhiguo; Xing, Liju; Liu, Xin

FGFR2 fusion/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA/RNA-based NGS and FISH

利用基于DNA/RNA的NGS和FISH技术分析肝内胆管癌中的FGFR2融合/重排。

Zhang, Xin; Bai, Qianming; Wang, Yulin; Jiang, Zhengzeng; Han, Jing; Xue, Cheng; Huang, Kai; Luan, Lijuan; Huang, Xiaoyong; Huang, Xiaowu; Shi, Guoming; Hou, Yingyong; Ji, Yuan

Distinguishing Low Expression Levels of Human Epidermal Growth Factor Receptor 2 in Breast Cancer: Insights from Qualitative and Quantitative Magnetic Resonance Imaging Analysis

区分乳腺癌中人表皮生长因子受体2低表达水平:来自定性和定量磁共振成像分析的启示

Shen, Yiyuan; Zhang, Xu; Zheng, Jinlong; Wang, Simin; Ding, Jie; Sun, Shiyun; Bai, Qianming; Fu, Caixia; Wang, Junlong; Gong, Jing; You, Chao; Gu, Yajia

m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3

m6A依赖的成熟miR-151-5p通过靶向LYPD3加速头颈部鳞状细胞癌的恶性进程。

Fei Huang #,Yuan Ren #,Yufei Hua,Ying Wang,Ruomeng Li,Ning Ji,Xin Zeng,Ding Bai,Qianming Chen,Xikun Zhou,Junjie Wu,Jing Li

Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL

弥漫性大B细胞淋巴瘤中通过二代测序检测到的MYC、BCL2和BCL6重排的特征和临床价值

Zeng, Yupeng; Wei, Ran; Bao, Longlong; Xue, Tian; Qin, Yulan; Ren, Min; Bai, Qianming; Yao, Qianlan; Yu, Chengli; Chen, Chen; Wei, Ping; Yu, Baohua; Cao, Junning; Li, Xiaoqiu; Zhang, Qunling; Zhou, Xiaoyan

Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer

中国专家对非小细胞肺癌MET检测临床实践的共识

Bai, Qianming; Shi, Xiaohua; Zhou, Xiaoyan; Liang, Zhiyong; Lu, Shun; Wu, Yilong